Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;34(2):123-35.

Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes

Affiliations
  • PMID: 19471237
Review

Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes

M Haase et al. Minerva Endocrinol. 2009 Jun.

Abstract

Relatively frequent, adrenal masses include a multitude of different tumor types: uni- or bilateral hyperplasias, adenomas, and the rare entity of adrenocortical carcinomas. With significant progress in our appreciation of their underlying molecular pathomechanisms and from analysis of affected individuals and their families, a number of inherited diseases and tumor syndromes have been linked to adrenocortical tumorigenesis. These syndromes and diseases include the Carney complex, the McCune-Albright syndrome, multiple endocrine neoplasia type 1, familial adenomatosis coli, congenital adrenal hyperplasia, familial forms of primary aldosteronism, the Beckwith-Wiedemann syndrome, and the Li-Fraumeni syndrome. The key to successful management of these syndromes is identification of patients harboring adrenal tumors within the context of hereditary diseases, since diagnostic procedures, therapy and follow-up may significantly differ from the management of sporadic, isolated adrenal tumors. This review explores the underlying genetic defects, diagnosis and therapy of the major heritable tumor syndromes associated with adrenocortical tumorigenesis.

PubMed Disclaimer

Similar articles

  • Genetic aspects of adrenocortical tumours and hyperplasias.
    Mazzuco TL, Durand J, Chapman A, Crespigio J, Bourdeau I. Mazzuco TL, et al. Clin Endocrinol (Oxf). 2012 Jul;77(1):1-10. doi: 10.1111/j.1365-2265.2012.04403.x. Clin Endocrinol (Oxf). 2012. PMID: 22471738 Review.
  • [Pathogenesis of adrenocortical cancer].
    Szabó D, Zsippai A, Bendes M, Tömböl Z, Szabó PM, Rácz K, Igaz P. Szabó D, et al. Orv Hetil. 2010 Jul 18;151(29):1163-70. doi: 10.1556/OH.2010.28931. Orv Hetil. 2010. PMID: 20591784 Review. Hungarian.
  • Mutations in adrenocortical tumors.
    Reincke M. Reincke M. Horm Metab Res. 1998 Jun-Jul;30(6-7):447-55. doi: 10.1055/s-2007-978913. Horm Metab Res. 1998. PMID: 9694578 Review.
  • Rare syndromes.
    Jabbour SA, Davidovici BB, Wolf R. Jabbour SA, et al. Clin Dermatol. 2006 Jul-Aug;24(4):299-316. doi: 10.1016/j.clindermatol.2006.04.005. Clin Dermatol. 2006. PMID: 16828412 Review.
  • Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS, McDonald KL, Robinson BG, Sidhu SB. Soon PS, et al. Oncologist. 2008 May;13(5):548-61. doi: 10.1634/theoncologist.2007-0243. Oncologist. 2008. PMID: 18515740 Review.

Cited by

Publication types

MeSH terms

LinkOut - more resources